AAPL337.39-7.24 (-2.10%) ▼|ABBV288.90-5.99 (-2.03%) ▼|ABT109.90+3.70 (+3.48%) ▲|ACN262.81+4.57 (+1.77%) ▲|ADBE255.00+4.77 (+1.91%) ▲|AMAT387.78-2.31 (-0.59%) ▼|AMD483.88-20.93 (-4.15%) ▼|AMGN466.59+0.58 (+0.12%) ▲|AMT188.18+0.40 (+0.21%) ▲|AMZN250.14+9.79 (+4.07%) ▲|AVGO329.94+3.86 (+1.18%) ▲|AXP328.87+9.76 (+3.06%) ▲|BA175.65+4.10 (+2.39%) ▲|BAC50.24+0.23 (+0.46%) ▲|BKNG155.04+6.91 (+4.66%) ▲|BLK1,174.62+27.08 (+2.36%) ▲|BMY62.46-0.02 (-0.03%) ▼|BNY148.30+1.19 (+0.81%) ▲|BRK-B554.76+12.27 (+2.26%) ▲|C123.82+1.85 (+1.52%) ▲|CAT623.25+0.50 (+0.08%) ▲|CL96.99+1.70 (+1.78%) ▲|CMCSA23.75+0.53 (+2.28%) ▲|COF212.07+7.22 (+3.52%) ▲|COP147.31-6.72 (-4.36%) ▼|COST1,039.22+26.94 (+2.66%) ▲|CRM232.27+3.10 (+1.35%) ▲|CSCO103.19-1.32 (-1.26%) ▼|CVS88.53-1.73 (-1.91%) ▼|CVX228.15-7.37 (-3.13%) ▼|DE664.40-11.08 (-1.64%) ▼|DHR229.50-2.73 (-1.18%) ▼|DIS113.60+2.66 (+2.40%) ▲|DUK127.93+0.54 (+0.42%) ▲|EMR168.41+3.47 (+2.10%) ▲|FDX319.72+6.44 (+2.06%) ▲|GD369.31-3.29 (-0.88%) ▼|GE315.95+14.15 (+4.69%) ▲|GEV877.20+19.33 (+2.25%) ▲|GILD170.19-0.49 (-0.29%) ▼|GM89.40+2.00 (+2.28%) ▲|GOOG281.97+3.75 (+1.35%) ▲|GOOGL283.48+3.64 (+1.30%) ▲|GS909.74+15.19 (+1.70%) ▲|HD339.46+10.26 (+3.12%) ▲|HON225.16+6.83 (+3.13%) ▲|IBM258.34+0.53 (+0.21%) ▲|INTC61.96-3.81 (-5.79%) ▼|INTU355.56+14.47 (+4.24%) ▲|ISRG444.94+12.93 (+2.99%) ▲|JNJ269.26-3.94 (-1.44%) ▼|JPM341.71+4.67 (+1.38%) ▲|KO95.69+1.61 (+1.71%) ▲|LIN521.96+7.72 (+1.50%) ▲|LLY1,412.61-4.93 (-0.35%) ▼|LMT641.11+4.16 (+0.65%) ▲|LOW216.26+7.19 (+3.44%) ▲|LRCX232.86-6.25 (-2.61%) ▼|MA659.63+21.62 (+3.39%) ▲|MCD263.87+5.75 (+2.23%) ▲|MDLZ66.05+1.11 (+1.70%) ▲|MDT98.69+2.15 (+2.23%) ▲|META612.09-2.90 (-0.47%) ▼|MMM179.35+5.01 (+2.87%) ▲|MO77.51-0.52 (-0.67%) ▼|MRK148.53-0.99 (-0.66%) ▼|MS186.52+2.22 (+1.20%) ▲|MSFT520.02-1.90 (-0.36%) ▼|MU852.74-32.00 (-3.62%) ▼|NEE84.99+1.28 (+1.52%) ▲|NFLX62.60+0.52 (+0.84%) ▲|NKE39.53+0.86 (+2.22%) ▲|NOW108.78+3.66 (+3.48%) ▲|NVDA206.58+1.94 (+0.95%) ▲|ORCL122.29-8.38 (-6.41%) ▼|PEP140.01+2.67 (+1.94%) ▲|PFE30.71+0.19 (+0.61%) ▲|PG163.79+2.22 (+1.37%) ▲|PLTR184.31+0.20 (+0.11%) ▲|PM208.04-0.75 (-0.36%) ▼|QCOM166.20+1.41 (+0.86%) ▲|RTX201.84+2.04 (+1.02%) ▲|SBUX103.86+0.21 (+0.20%) ▲|SCHW89.25+1.20 (+1.36%) ▲|SO94.31+0.60 (+0.64%) ▲|SPG222.83+5.08 (+2.33%) ▲|T21.44+0.03 (+0.14%) ▲|TMO685.44-11.56 (-1.66%) ▼|TMUS158.56+2.12 (+1.36%) ▲|TSLA408.55+8.74 (+2.18%) ▲|TXN308.30+7.46 (+2.48%) ▲|UBER67.19+1.94 (+2.97%) ▲|UNH397.41-9.57 (-2.35%) ▼|UNP307.49+3.49 (+1.15%) ▲|UPS109.57+1.32 (+1.22%) ▲|USB60.52+1.07 (+1.80%) ▲|V426.08+12.49 (+3.02%) ▲|VZ44.94+0.21 (+0.46%) ▲|WFC84.96+1.56 (+1.86%) ▲|WMT126.97+3.46 (+2.80%) ▲|XOM180.46-6.79 (-3.63%) ▼|AAPL337.39-7.24 (-2.10%) ▼|ABBV288.90-5.99 (-2.03%) ▼|ABT109.90+3.70 (+3.48%) ▲|ACN262.81+4.57 (+1.77%) ▲|ADBE255.00+4.77 (+1.91%) ▲|AMAT387.78-2.31 (-0.59%) ▼|AMD483.88-20.93 (-4.15%) ▼|AMGN466.59+0.58 (+0.12%) ▲|AMT188.18+0.40 (+0.21%) ▲|AMZN250.14+9.79 (+4.07%) ▲|AVGO329.94+3.86 (+1.18%) ▲|AXP328.87+9.76 (+3.06%) ▲|BA175.65+4.10 (+2.39%) ▲|BAC50.24+0.23 (+0.46%) ▲|BKNG155.04+6.91 (+4.66%) ▲|BLK1,174.62+27.08 (+2.36%) ▲|BMY62.46-0.02 (-0.03%) ▼|BNY148.30+1.19 (+0.81%) ▲|BRK-B554.76+12.27 (+2.26%) ▲|C123.82+1.85 (+1.52%) ▲|CAT623.25+0.50 (+0.08%) ▲|CL96.99+1.70 (+1.78%) ▲|CMCSA23.75+0.53 (+2.28%) ▲|COF212.07+7.22 (+3.52%) ▲|COP147.31-6.72 (-4.36%) ▼|COST1,039.22+26.94 (+2.66%) ▲|CRM232.27+3.10 (+1.35%) ▲|CSCO103.19-1.32 (-1.26%) ▼|CVS88.53-1.73 (-1.91%) ▼|CVX228.15-7.37 (-3.13%) ▼|DE664.40-11.08 (-1.64%) ▼|DHR229.50-2.73 (-1.18%) ▼|DIS113.60+2.66 (+2.40%) ▲|DUK127.93+0.54 (+0.42%) ▲|EMR168.41+3.47 (+2.10%) ▲|FDX319.72+6.44 (+2.06%) ▲|GD369.31-3.29 (-0.88%) ▼|GE315.95+14.15 (+4.69%) ▲|GEV877.20+19.33 (+2.25%) ▲|GILD170.19-0.49 (-0.29%) ▼|GM89.40+2.00 (+2.28%) ▲|GOOG281.97+3.75 (+1.35%) ▲|GOOGL283.48+3.64 (+1.30%) ▲|GS909.74+15.19 (+1.70%) ▲|HD339.46+10.26 (+3.12%) ▲|HON225.16+6.83 (+3.13%) ▲|IBM258.34+0.53 (+0.21%) ▲|INTC61.96-3.81 (-5.79%) ▼|INTU355.56+14.47 (+4.24%) ▲|ISRG444.94+12.93 (+2.99%) ▲|JNJ269.26-3.94 (-1.44%) ▼|JPM341.71+4.67 (+1.38%) ▲|KO95.69+1.61 (+1.71%) ▲|LIN521.96+7.72 (+1.50%) ▲|LLY1,412.61-4.93 (-0.35%) ▼|LMT641.11+4.16 (+0.65%) ▲|LOW216.26+7.19 (+3.44%) ▲|LRCX232.86-6.25 (-2.61%) ▼|MA659.63+21.62 (+3.39%) ▲|MCD263.87+5.75 (+2.23%) ▲|MDLZ66.05+1.11 (+1.70%) ▲|MDT98.69+2.15 (+2.23%) ▲|META612.09-2.90 (-0.47%) ▼|MMM179.35+5.01 (+2.87%) ▲|MO77.51-0.52 (-0.67%) ▼|MRK148.53-0.99 (-0.66%) ▼|MS186.52+2.22 (+1.20%) ▲|MSFT520.02-1.90 (-0.36%) ▼|MU852.74-32.00 (-3.62%) ▼|NEE84.99+1.28 (+1.52%) ▲|NFLX62.60+0.52 (+0.84%) ▲|NKE39.53+0.86 (+2.22%) ▲|NOW108.78+3.66 (+3.48%) ▲|NVDA206.58+1.94 (+0.95%) ▲|ORCL122.29-8.38 (-6.41%) ▼|PEP140.01+2.67 (+1.94%) ▲|PFE30.71+0.19 (+0.61%) ▲|PG163.79+2.22 (+1.37%) ▲|PLTR184.31+0.20 (+0.11%) ▲|PM208.04-0.75 (-0.36%) ▼|QCOM166.20+1.41 (+0.86%) ▲|RTX201.84+2.04 (+1.02%) ▲|SBUX103.86+0.21 (+0.20%) ▲|SCHW89.25+1.20 (+1.36%) ▲|SO94.31+0.60 (+0.64%) ▲|SPG222.83+5.08 (+2.33%) ▲|T21.44+0.03 (+0.14%) ▲|TMO685.44-11.56 (-1.66%) ▼|TMUS158.56+2.12 (+1.36%) ▲|TSLA408.55+8.74 (+2.18%) ▲|TXN308.30+7.46 (+2.48%) ▲|UBER67.19+1.94 (+2.97%) ▲|UNH397.41-9.57 (-2.35%) ▼|UNP307.49+3.49 (+1.15%) ▲|UPS109.57+1.32 (+1.22%) ▲|USB60.52+1.07 (+1.80%) ▲|V426.08+12.49 (+3.02%) ▲|VZ44.94+0.21 (+0.46%) ▲|WFC84.96+1.56 (+1.86%) ▲|WMT126.97+3.46 (+2.80%) ▲|XOM180.46-6.79 (-3.63%) ▼|
19.6 C
New York
Monday, November 2, 2026

Tag: company

newsFORsourcecompanycontentinformationreleases1market

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates

MELVILLE, N.Y., June 18, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to announce that its Chief Executive Officer, Lance Alstodt, will be interviewed during the Benzinga All-Access Show today, Wednesday, June 18, 2025, at 10:50 a.m. Eastern time.

Thousands and Wildcard Announce $9M Fundraise Co-Led by Arbitrum Gaming Ventures and Paradigm

MCKINNEY, Texas, June 18, 2025 /PRNewswire/ -- Thousands, a revolutionary web3 protocol that transforms word-of-mouth marketing into a universal attribution infrastructure - together with...

Cannon Resources Announces Major Resource Expansion and Significant Development Momentum at Fisher East Nickel Project

Updated Resource, High-Grade Discovery, and Accelerated De-risking Underscore Fisher East's Strategic Value in the Global Critical Materials Supply Chain TORONTO and PERTH, Australia, June 18,...

Mosaicx Launches AI-Native CX Platform and Wins Top Honor at CCW Las Vegas 2025

Recognized for innovation and inclusion, Mosaicx debuts next-generation Engage platform and earns Best Workplace for Gender Equity Award 
Recognized for innovation and inclusion, Mosaicx debuts next-generation Engage platform and earns Best Workplace for Gender Equity Award

Cannon Resources Announces Major Resource Expansion and Significant Development Momentum at Fisher East Nickel Project

Updated Resource, High-Grade Discovery, and Accelerated De-risking Underscore Fisher East's Strategic Value in the Global Critical Materials Supply Chain TORONTO and PERTH, Australia, June 18,...

Cannon Resources Announces Major Resource Expansion and Significant Development Momentum at Fisher East Nickel Project

Updated Resource, High-Grade Discovery, and Accelerated De-risking Underscore Fisher East's Strategic Value in the Global Critical Materials Supply Chain TORONTO and PERTH, Australia, June 18,...

Intellias at Software-Defined Vehicles USA 2025: Special Plenary Presentation Will Examine “The Fragmented Future of the Software-Defined Vehicle – Cooperation or Chaos?”

Company to Showcase Newest Functions of its "IntelliKit" Chip-To-Cloud Automotive Technology Platform CHICAGO, June 18, 2025 /PRNewswire/ -- Leading OEM software engineering partner and solution provider...

Oklahoma Cancer Specialists and Research Institute Selects BioCareSD and AllyGPO as Primary Drug Distributor and GPO Partner

TULSA, Okla., June 18, 2025 /PRNewswire/ -- Oklahoma Cancer Specialists and Research Institute (OCSRI), a leading independent community oncology practice, has officially selected BioCareSD and AllyGPO as its primary...

Persona-Triangle Announces Arron Yount as CEO

Veteran operations executive with proven track record of scaling multi-divisional, facility services businesses to lead next phase of growth WATERTOWN, S.D., June 18, 2025 /PRNewswire/...

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

-  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation

EASTPLATS ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

VANCOUVER, BC, June 18, 2025 /CNW/ - Eastern Platinum Limited (TSX: ELR) (JSE: EPS) ("Eastplats" or the "Company") announces the voting results of the...

Seeq Corporation Named to Inc.’s 2025 Best Workplaces List

Annual list recognizes the businesses that set the standard for workplace success and awards excellence in company culture SEATTLE, June 18, 2025 /PRNewswire/ -- Seeq...

PureBulk Unveils New Filler-Free Electrolyte Mix for Keto Hydration

ROSEBURG, Ore., June 18, 2025 /PRNewswire/ -- PureBulk, a provider of high-purity, clean supplements, today announced the launch of its new product, Tasty Clear...

Ormat Announces the Completion of Its Acquisition of the Blue Mountain Geothermal Power Plant From Cyrq Energy

RENO, Nev., June 18, 2025 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA), (the “Company” or “Ormat”), a leading geothermal and renewable energy company, announced today that it has closed its previously disclosed acquisition of the Blue Mountain geothermal power plant from Cyrq Energy. Under the agreement, Ormat paid $88 million for 100% of the equity interest in the 20MW power plant.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers